Abstract：
Hyperglycemia is common in hospitalized patients and is traditionally managed with scheduled and correctional doses of insulin. The authors present an overview of the latest (2022) guidelines from the Endocrine Society on inpatient hyperglycemia management in noncritically ill patients, which includes a role for newer diabetes technologies and nontraditional insulin and noninsulin therapies.
摘要：
高血糖在住院患者中很常见，传统上使用计划剂量和校正剂量的胰岛素进行管理。作者概述了内分泌学会关于非危重患者住院高血糖管理的最新（2022年）指南。其中包括新的糖尿病技术和非传统胰岛素和非胰岛素治疗的作用。
